BUZZ - FMC shares fall due to the US launching a new kidney care strategy

October 21 - ** The share price of dialysis service provider Fresenius Medical Care FMEG.DE fell by about 2%, dropping to the bottom of the German blue-chip DAX index .GDAXI

** A local trader pointed out that the U.S. Department of Health and Human Services announced a new kidney care strategy on Tuesday (link)

** Berenberg analyst Harry Gillis pointed out that the plan is crucial for FMC and its U.S. competitor DaVita DVA.N, highlighting potential reviews focused on partnerships with nephrologists, Medicare Advantage pricing, and charities that help patients pay insurance premiums

** “Although there are no changes today, the market is reacting to long-term risks to profitability,” Gillis said

** Metzler analyst Victor Beyer said the plan could bring uncertainty to FMC's future market share and reimbursement environment

** FMC welcomed the initiative and said in a statement that its focus on innovation, home dialysis, and organ transplantation aligns with its strategy

(To assist non-English speakers, Reuters has automated the translation of its reports into several other languages. Because automated translation may contain errors or lack required context, Reuters does not guarantee the accuracy of this translated text and provides it for the convenience of readers only. Reuters accepts no responsibility for any loss or damage incurred as a result of using the automated translation function.)